Thursday, 25th of September 2014 |
FIVE ITEMS ON MEASLES AND MEASLES VACCINATION, INCLUDING POWER POINTS FROM THE WASHINGTON MEASLES/RUBELLA MEETING
A SHORT CLINICAL REVIEW OF VACCINATION AGAINST MEASLES
http://www.measlesupdates.org/?content=com_articles&artid=1986
A RANDOMIZED TRIAL OF A STANDARD DOSE OF EDMONSTON-ZAGREB VACCINE GIVEN AT 4.5 MONTHS: EFFECT ON HOSPITAL ADMISSIONS
http://www.measlesupdates.org/?content=com_articles&artid=1985
MEASLES ANTIBODY LEVELS AFTER VACCINATION WITH EDMONSTON-ZAGREB AND SCHWARZ VACCINES AT 9 AND 18 MONTHS OF AGE
http://www.measlesupdates.org/?content=com_articles&artid=1984
INFLUENCE OF VACCINATION DOSE AND CLINICO-DEMOGRAPHIC FACTORS ON ANTIBODY TITERS
http://www.measlesupdates.org/?content=com_articles&artid=1983
POWER POINT PRESENTATIONS FROM THE 13TH ANNUAL ADVOCACY MEETING FOR MEASLES AND RUBELLA/CRS ERADICATION
http://www.measlesupdates.org/?content=com_articles&artid=1982
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41210054 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |